Guangzhou Boji Medical & Biotechnological Co Ltd operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangzhou Boji Medical & Biotechnological Co Ltd with three other
pharmaceutical manufacturers in Asia:
Biotoxtech Company Limited
of KOREA (SOUTH)
sales of 25.85 billion Korean Won [US$20.89 million]
Ina Research Incorporation
(2.59 billion Japanese Yen [US$23.99 million]
Clearbridge Health Ltd
based in SINGAPORE
(21.53 million Singapore Dollars [US$15.15 million]
During the year ended December of 2019, sales at
Guangzhou Boji Medical & Biotechnological Co Ltd were 224.06 million Chinese Renmimbi (US$31.25 million).
increase of 30.2%
versus 2018, when the company's sales were 172.04 million Chinese Renmimbi.
This was the third consecutive year of growth at Guangzhou Boji Medical & Biotechnological Co Ltd.
Sales of Clinical Research Service saw an increase
48.9% in 2019, from
105.63 million Chinese Renmimbi to 157.27 million Chinese Renmimbi.
Not all segments of Guangzhou Boji Medical & Biotechnological Co Ltd experienced an increase in sales in 2019:
sales of Technical Achievement Transformation Ser fell 48.3% to 943,396.23 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).